The UK’s state-run health service said Thursday it will not offer two new treatments for Alzheimer’s disease, citing high costs and “too small” benefits.
The UK’s state-run health service said Thursday it will not offer two new treatments for Alzheimer’s disease, citing high costs and “too small” benefits.